Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,400 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
BMC Medicine, 2023Integrated unbiased multiomics defines disease-independent placental clusters in common obstetrical syndromes
Barak O., Lovelace T., Piekos S. et al.
Olink Target 96
European Journal of Epidemiology, 2023Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults
Yao P., Iona A., Kartsonaki C. et al.
Olink Explore 3072/384
Clinical and Experimental Dermatology, 2023HLA-C*15:02 and epidermal growth factor receptor inhibitor-induced erosive pustular dermatosis of the scalp
Zhang Y., Grice S., Wang N. et al.
Neurobiology of Disease, 2023Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach
Maple-Grødem J., Ushakova A., Pedersen K. et al.
Translational Neurodegeneration, 2023Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
Paslawski W., Khosousi S., Hertz E. et al.
Clinical Immunology, 2023Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children
Amodio D., Pascucci G., Cotugno N. et al.
Alimentary Pharmacology & Therapeutics, 2023Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease
Ungaro R., Hu L., Ji J. et al.
Journal of the American Heart Association, 2023Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study
Xu Q., Sun L., Wang Y. et al.
Science Translational Medicine, 2023A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Van Damme K., Hoste L., Declercq J. et al.
Arthritis & Rheumatology, 2023Elevation of IL‐17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders
Brodeur K., Liu M., Ibanez D. et al.
Olink Target 48
Journal for ImmunoTherapy of Cancer, 2023Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer
Anker J., Pal S., Kim-Schulze S. et al.
Journal of Cancer Research and Clinical Oncology, 2023Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study
Pham T., Nimptsch K., Papadimitriou N. et al.
Antioxidants, 2023Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents
Ullah A., Stankevic E., Holm L. et al.
Journal of Cerebral Blood Flow & Metabolism, 2023A cluster of blood-based protein biomarkers associated with decreased cerebral blood flow relates to future cardiovascular events in patients with cardiovascular disease
Overmars L., Kuipers S., van Es B. et al.
iScience, 2023Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19
Shivram H., Hackney J., Rosenberger C. et al.
eClinicalMedicine, 2023Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study
Zinzani P., Trněný M., Ribrag V. et al.
Nature Genetics, 2023Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis
Zhou S., Sosina O., Bovijn J. et al.
Research and Practice in Thrombosis and Haemostasis, 2023Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach
Liu Z., McCutcheon F., Ho H. et al.
Brain, Behavior, and Immunity, 2023Machine learning models of plasma proteomic data predict mood in chronic stroke and tie it to aberrant peripheral immune responses
Bidoki N., Zera K., Nassar H. et al.
Nature Aging, 2023Multivariate genome-wide analysis of aging-related traits identifies novel loci and new drug targets for healthy aging
Rosoff D., Mavromatis L., Bell A. et al.
3478 publications
Items per page
2541-2560 of 3478 publications